http://altimmune.com
Altimmune, Inc. Company Intro
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Industry
Healthcare
Altimmune, Inc. Headquaters
910 Clopper Road
Gaithersburg,20878
United States
Altimmune, Inc. Share price
28 Jan 2021 01:04 GMT
$15.70
-0.46 (-2.85 %)
Altimmune, Inc. Market cap
$505.515 M
WMC RANKING
2021
Altimmune, Inc. # 217
BiotechnologyLatest Altimmune, Inc. News
27 Jan 2021
Clinical Treatment for Covid-19 Market Size Global Industry ...
... Clover Biopharmaceuticals, ExpreS2ion Biotechnologies ApS, Bravovax, Altimmune, Janssen Pharmaceuticals, iBio Pharma Inc, Greffex Inc., Ascletis Pharma ...
27 Jan 2021
The Trend in Altimmune, Inc. (NASDAQ:ALT) Continues to Point Skyward
Altimmune, Inc. (NASDAQ:ALT) price closed lower on Tuesday, Jan 26, sinking -4.38% below its previous close. Get the hottest stocks to trade every day before ...
27 Jan 2021
COVID-19 Treatment Market Global Industry Analysis, size ...
... Altimmune, Greffex Inc., CanSino Biologics, Inc., ExpreS2ion Biotechnologies ApS, Clover Biopharmaceuticals, Vaxil Bio Ltd., iBio Pharma Inc, Tonix ...
WMC Market Score
WMC Market to Revenue Score
Altimmune, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Altimmune, Inc. | USD | $6,448 | $54,809 | $-42,519 | $5,055M | 217 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $550,130B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $340,530B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $585,740B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $263,140B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Altimmune, Inc. Social Followers vs Top 4 Industry Competitors
Altimmune, Inc. Post vs Top 4 Industry Competitors
Altimmune, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Altimmune, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Altimmune, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Altimmune, Inc. | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.55 | 10.99 | 100 | 0 | 0 | 93.89 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 60 | 0 | 0 | 93.45 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.26 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
